66 related articles for article (PubMed ID: 37572639)
41. Therapeutic potential of traditional Chinese medicine in atherosclerosis: A review.
Liu H; Zhu L; Chen L; Li L
Phytother Res; 2022 Nov; 36(11):4080-4100. PubMed ID: 36029188
[TBL] [Abstract][Full Text] [Related]
42. Emerging approaches of traditional Chinese medicine formulas for the treatment of hyperlipidemia.
Xie W; Zhao Y; Du L
J Ethnopharmacol; 2012 Mar; 140(2):345-67. PubMed ID: 22306102
[TBL] [Abstract][Full Text] [Related]
43. Can highly cited herbs in ancient Traditional Chinese medicine formulas and modern publications predict therapeutic targets for diabetes mellitus?
Wang H; Shi S; Wang S
J Ethnopharmacol; 2018 Mar; 213():101-110. PubMed ID: 29102765
[TBL] [Abstract][Full Text] [Related]
44. [Modernization of Chinese medicine Salviae Miltiorrhizae Radix et Rhizoma: a review].
Ma XJ; Yang J; Ma GR; Zeng W; Guo J; Ma Y
Zhongguo Zhong Yao Za Zhi; 2022 Oct; 47(19):5131-5139. PubMed ID: 36472020
[TBL] [Abstract][Full Text] [Related]
45. Potential role of oral thiazolidinedione therapy in preserving beta-cell function in type 2 diabetes mellitus.
Walter H; Lübben G
Drugs; 2005; 65(1):1-13. PubMed ID: 15610048
[TBL] [Abstract][Full Text] [Related]
46. Modulation of the pancreatic islet-stress axis as a novel potential therapeutic target in diabetes mellitus.
Ludwig B; Barthel A; Reichel A; Block NL; Ludwig S; Schally AV; Bornstein SR
Vitam Horm; 2014; 95():195-222. PubMed ID: 24559919
[TBL] [Abstract][Full Text] [Related]
47. [Review of chemical composition, pharmacological effects, and clinical application of Salviae Miltiorrhizae Radix et Rhizoma and prediction of its Q-markers].
Shan XX; Hong BZ; Liu J; Wang GK; Chen WD; Yu NJ; Peng DY; Wang L; Zhang CY
Zhongguo Zhong Yao Za Zhi; 2021 Nov; 46(21):5496-5511. PubMed ID: 34951201
[TBL] [Abstract][Full Text] [Related]
48. Protection of pancreatic beta-cells: is it feasible?
Bonora E
Nutr Metab Cardiovasc Dis; 2008 Jan; 18(1):74-83. PubMed ID: 18096375
[TBL] [Abstract][Full Text] [Related]
49. Use of preclinical models to identify markers of type 2 diabetes susceptibility and novel regulators of insulin secretion - A step towards precision medicine.
Thorens B; Rodriguez A; Cruciani-Guglielmacci C; Wigger L; Ibberson M; Magnan C
Mol Metab; 2019 Sep; 27S(Suppl):S147-S154. PubMed ID: 31500826
[TBL] [Abstract][Full Text] [Related]
50. Pancreatic β-cell failure, clinical implications, and therapeutic strategies in type 2 diabetes.
Cui D; Feng X; Lei S; Zhang H; Hu W; Yang S; Yu X; Su Z
Chin Med J (Engl); 2024 Apr; 137(7):791-805. PubMed ID: 38479993
[TBL] [Abstract][Full Text] [Related]
51. Role of Cell-Based Therapies in T2D.
Ashe S; Hebrok M
Semin Nephrol; 2023 May; 43(3):151432. PubMed ID: 37918206
[TBL] [Abstract][Full Text] [Related]
52. The Impact of Taurine on Obesity-Induced Diabetes Mellitus: Mechanisms Underlying Its Effect.
Ahmed K; Choi HN; Yim JE
Endocrinol Metab (Seoul); 2023 Oct; 38(5):482-492. PubMed ID: 37846056
[TBL] [Abstract][Full Text] [Related]
53. High-Throughput Methods for the Discovery of Small Molecule Modulators of Pancreatic Beta-Cell Function and Regeneration.
McCarty SM; Clasby MC; Sexton JZ
Assay Drug Dev Technol; 2024 Apr; 22(3):148-159. PubMed ID: 38526231
[No Abstract] [Full Text] [Related]
54. Central Nervous System Control of Glucose Homeostasis: A Therapeutic Target for Type 2 Diabetes?
Mirzadeh Z; Faber CL; Schwartz MW
Annu Rev Pharmacol Toxicol; 2022 Jan; 62():55-84. PubMed ID: 34990204
[TBL] [Abstract][Full Text] [Related]
55. β-cell neogenesis: A rising star to rescue diabetes mellitus.
Niu F; Liu W; Ren Y; Tian Y; Shi W; Li M; Li Y; Xiong Y; Qian L
J Adv Res; 2023 Oct; ():. PubMed ID: 37839502
[TBL] [Abstract][Full Text] [Related]
56. Animal Models for Understanding the Mechanisms of Beta Cell Death during Type 2 Diabetes Pathogenesis.
Covington BA; Chen W
Biomedicines; 2024 Feb; 12(3):. PubMed ID: 38540087
[TBL] [Abstract][Full Text] [Related]
57. Positive Effects of Physical Activity on Insulin Signaling.
Małkowska P
Curr Issues Mol Biol; 2024 May; 46(6):5467-5487. PubMed ID: 38920999
[TBL] [Abstract][Full Text] [Related]
58. Role of stilbenes against insulin resistance: A review.
Shazmeen ; Haq IU; Rajoka MSR; Asim Shabbir M; Umair M; Llah IU; Manzoor MF; Nemat A; Abid M; Khan MR; Aadil RM
Food Sci Nutr; 2021 Nov; 9(11):6389-6405. PubMed ID: 34760269
[TBL] [Abstract][Full Text] [Related]
59. Verapamil chronicles: advances from cardiovascular to pancreatic β-cell protection.
Arefanian H; Koti L; Sindhu S; Ahmad R; Al Madhoun A; Al-Mulla F
Front Pharmacol; 2023; 14():1322148. PubMed ID: 38089047
[TBL] [Abstract][Full Text] [Related]
60. The Current State of Beta-Cell-Mass PET Imaging for Diabetes Research and Therapies.
Cheung P; Eriksson O
Biomedicines; 2021 Dec; 9(12):. PubMed ID: 34944640
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
